Literature DB >> 32126556

Voice-Based Classification of Amyotrophic Lateral Sclerosis: Where Are We and Where Are We Going? A Systematic Review.

Helder Vieira1, Nelson Costa1, Tomás Sousa1, Sara Reis1,2, Luis Coelho3,4.   

Abstract

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal progressive motor neuron disease. People with ALS demonstrate various speech problems.
SUMMARY: We aim to provide an overview of studies concerning the diagnosis of ALS based on the analysis of voice samples. The main focus is on the feasibility of the use of voice and speech assessment as an effective method to diagnose the disease, either in clinical or pre-clinical conditions, and to monitor the disease progression. Specifically, we aim to examine current knowledge on: (a) voice parameters and the data models that can, most effectively, provide robust results; (b) the feasibility of a semi-automatic or automatic diagnosis and outcomes; and (c) the factors that can improve or restrict the use of such systems in a real-world context. Key Messages: The studies already carried out on the possibility of diagnosis of ALS using the voice signal are still sparse but all point to the importance, feasibility and simplicity of this approach. Most cohorts are small which limits the statistical relevance and makes it difficult to infer broader conclusions. The set of features used, although diverse, is quite circumscribed. ALS is difficult to diagnose early because it may mimic several other neurological diseases. Promising results were found for the automatic detection of ALS from speech samples and this can be a feasible process even in pre-symptomatic stages. Improved guidelines must be set in order to establish a robust decision model.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Bulbar onset; Classification; Diagnosis; Speech; Voice

Year:  2020        PMID: 32126556     DOI: 10.1159/000506259

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  3 in total

1.  Repeatability of Commonly Used Speech and Language Features for Clinical Applications.

Authors:  Gabriela M Stegmann; Shira Hahn; Julie Liss; Jeremy Shefner; Seward B Rutkove; Kan Kawabata; Samarth Bhandari; Kerisa Shelton; Cayla Jessica Duncan; Visar Berisha
Journal:  Digit Biomark       Date:  2020-12-02

2.  Early detection and tracking of bulbar changes in ALS via frequent and remote speech analysis.

Authors:  Gabriela M Stegmann; Shira Hahn; Julie Liss; Jeremy Shefner; Seward Rutkove; Kerisa Shelton; Cayla Jessica Duncan; Visar Berisha
Journal:  NPJ Digit Med       Date:  2020-10-13

Review 3.  Biomedical signals and machine learning in amyotrophic lateral sclerosis: a systematic review.

Authors:  Felipe Fernandes; Ingridy Barbalho; Daniele Barros; Ricardo Valentim; César Teixeira; Jorge Henriques; Paulo Gil; Mário Dourado Júnior
Journal:  Biomed Eng Online       Date:  2021-06-15       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.